114 related articles for article (PubMed ID: 16298583)
21. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis.
Moreno Planas JM; Rubio González E; Boullosa Graña E; Fernández Ruiz M; Jiménez Garrido M; Lucena de la Poza JL; Martínez Arrieta F; Molina Miliani C; Sánchez Turrión V; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1482-3. PubMed ID: 15866647
[TBL] [Abstract][Full Text] [Related]
23. [Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis].
Park JI; Choi KM; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2007 Dec; 13(4):543-55. PubMed ID: 18159152
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
Lengyel G; Tulassay Z
Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
[TBL] [Abstract][Full Text] [Related]
25. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
Schmitz V; Kiessling A; Bahra M; Puhl G; Kahl A; Berg T; Neuhaus R; Neuhaus P; Neumann U
Ann Transplant; 2007; 12(3):22-7. PubMed ID: 18290566
[TBL] [Abstract][Full Text] [Related]
26. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
[TBL] [Abstract][Full Text] [Related]
27. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
Ross AS; Bhan AK; Pascual M; Thiim M; Benedict Cosimi A; Chung RT
Clin Transplant; 2004 Apr; 18(2):166-73. PubMed ID: 15016131
[TBL] [Abstract][Full Text] [Related]
28. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
Di Bisceglie AM; Ghalib RH; Hamzeh FM; Rustgi VK
J Viral Hepat; 2007 Oct; 14(10):721-9. PubMed ID: 17875007
[TBL] [Abstract][Full Text] [Related]
29. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
Formann E; Steindl-Munda P; Hofer H; Jessner W; Bergholz U; Gurguta C; Ferenci P
Aliment Pharmacol Ther; 2006 Feb; 23(4):507-11. PubMed ID: 16441471
[TBL] [Abstract][Full Text] [Related]
31. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination.
Dumortier J; Scoazec JY; Chevallier P; Boillot O
J Hepatol; 2004 Apr; 40(4):669-74. PubMed ID: 15030984
[TBL] [Abstract][Full Text] [Related]
32. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.
Forns X; García-Retortillo M; Serrano T; Feliu A; Suarez F; de la Mata M; García-Valdecasas JC; Navasa M; Rimola A; Rodés J
J Hepatol; 2003 Sep; 39(3):389-96. PubMed ID: 12927925
[TBL] [Abstract][Full Text] [Related]
33. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
34. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
35. [Severe relapse of hepatitis C following liver transplantation. Successful treatment with a combination of interferon-alpha and ribavirin].
Telegdy L; Görög D; Horányi M; Schaff Z
Orv Hetil; 1999 Aug; 140(34):1891-3. PubMed ID: 10502972
[TBL] [Abstract][Full Text] [Related]
36. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
37. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
Baker RD; Dee D; Baker SS
J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
[TBL] [Abstract][Full Text] [Related]
38. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
[TBL] [Abstract][Full Text] [Related]
39. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
40. Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
Moreno Planas JM; Rubio Gonzalez E; Boullosa Graña E; Garrido Botella A; Barrios Peinado C; Lucena Poza JL; Jiménez Garrido M; Sanchez Turrion V; Cuervas-Mons Martinez V
Transplant Proc; 2005 Jun; 37(5):2207-8. PubMed ID: 15964380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
